Shayne & Co., LLC Bristol Myers Squibb CO Transaction History

Shayne & Co., LLC

$356 Million
Q2 2024

A detailed history of Shayne & Co., LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Shayne & Co., LLC holds 39,417 shares of BMY stock, worth $1.93 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

39,417

Previous 9,844 300.42%

Holding current value

$1.93 Million

Previous $533,000 206.94%

% of portfolio

0.46%

Previous 0.15%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$40.25 - $52.99 $1.19 Million - $1.57 Million	29,573 Added 300.42%	39,417 $1.64 Million
Q1 2024 May 08, 2024	BUY	$47.98 - $54.4 $4,366 - $4,950	91 Added 0.93%	9,844 $533,000
Q4 2023 Feb 07, 2024	SELL	$48.48 - $57.85 $25,112 - $29,966	-518 Reduced 5.04%	9,753 $500,000
Q3 2023 Nov 08, 2023	BUY	$57.89 - $64.73 $76,299 - $85,314	1,318 Added 14.72%	10,271 $596,000
Q2 2023 Aug 04, 2023	BUY	$63.71 - $70.74 $3,822 - $4,244	60 Added 0.67%	8,953 $572,000

Q1 2023 May 04, 2023	BUY	$65.71 - $74.53 $82,597 - $93,684	1,257 Added 16.46%	8,893 $616,000
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $3,355 - $3,973	49 Added 0.65%	7,636 $549,000
Q3 2022 Oct 21, 2022	BUY	$0.13 - $76.84 $6 - $3,995	52 Added 0.69%	7,587 $539,000
Q2 2022 Jul 22, 2022	BUY	$72.62 - $79.98 $3,703 - $4,078	51 Added 0.68%	7,535 $580,000
Q1 2022 Apr 25, 2022	BUY	$61.48 - $73.72 $3,565 - $4,275	58 Added 0.78%	7,484 $547,000
Q4 2021 Feb 07, 2022	BUY	$53.63 - $62.52 $155,956 - $181,808	2,908 Added 64.36%	7,426 $463,000
Q3 2021 Oct 27, 2021	BUY	$59.17 - $69.31 $1,715 - $2,009	29 Added 0.65%	4,518 $267,000
Q2 2021 Jul 29, 2021	BUY	$61.91 - $67.42 $1,857 - $2,022	30 Added 0.67%	4,489 $300,000
Q1 2021 Apr 30, 2021	BUY	$59.34 - $66.74 $1,780 - $2,002	30 Added 0.68%	4,459 $281,000
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $1,616 - $1,832	28 Added 0.64%	4,429 $275,000
Q3 2020 Nov 09, 2020	BUY	$57.43 - $63.64 $1,722 - $1,909	30 Added 0.69%	4,401 $265,000
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $1,589 - $1,858	29 Added 0.67%	4,371 $257,000
Q1 2020 May 05, 2020	BUY	$46.4 - $67.43 $1,206 - $1,753	26 Added 0.6%	4,342 $242,000
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $1,377 - $1,797	28 Added 0.65%	4,316 $277,000
Q3 2019 Oct 29, 2019	BUY	$42.77 - $50.71 $183,397 - $217,444	4,288 New	4,288 $217,000
Q2 2019 Jul 24, 2019	SELL	$44.62 - $49.34 $188,385 - $208,313	-4,222 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$45.12 - $53.8 $1,353 - $1,614	30 Added 0.72%	4,222 $201,000
Q4 2018 Feb 12, 2019	BUY	$48.76 - $63.23 $1,414 - $1,833	29 Added 0.7%	4,192 $218,000
Q3 2018 Oct 29, 2018	BUY	$55.19 - $62.25 $1,324 - $1,494	24 Added 0.58%	4,163 $258,000
Q2 2018 Jul 26, 2018	BUY	$50.53 - $62.98 $1,414 - $1,763	28 Added 0.68%	4,139 $229,000
Q1 2018 Apr 19, 2018	BUY	$59.92 - $68.98 $1,318 - $1,517	22 Added 0.54%	4,111 $260,000
Q4 2017 Jan 25, 2018	BUY	$59.94 - $65.35 $1,378 - $1,503	23 Added 0.57%	4,089 $251,000
Q3 2017 Nov 01, 2017	BUY	$55.23 - $63.74 $224,565 - $259,166	4,066	4,066 $259,000

Others Institutions Holding BMY

# of Institutions

2,475

Shares Held

1.49B

Call Options Held

26M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $104B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shayne & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shayne & Co., LLC with notifications on news.

Account